As the largest dedicated TB vaccine research group on the African continent, SATVI (South African TB Vaccine Initiative) conducts clinical TB vaccine research with the ultimate goal of developing a new, effective and affordable TB vaccine, which has the potential to save hundreds of thousands of lives globally.